Immunomodulatory and anti-inflammatory properties of an orally bioavailable sod-gliadin complex

Authors

  • Eric Postaire Académie nationale de Pharmacie, 4 avenue de l’Observatoire, F75006 Paris, France
  • Laurent Intes Isocell, 53 rue du Général Marcial Vallin, F75015 Paris, France
  • François Vix Isocell, 53 rue du Général Marcial Vallin, F75015 Paris, France

DOI:

https://doi.org/10.37022/jpmhs.v5i4.84

Keywords:

Superoxide dismustase, Gliadin, Anti-inflammatories activities, Immunomodulatory properties, fibrosis, antioxidant

Abstract

Superoxide Dismutase (SOD) constitutes part of the body’s front line in antioxidant defenses, helping to maintain the physiological oxidant-antioxidant balance. However, this balance can be disrupted by a number of factors that include aging, smoking, pollution, exposure to sunlight, high intensity exercise, infection and the subsequent immune response. The body experiences oxidative stress under these types of conditions, which has been linked to the increased risk of chronic disease. Oral supplementation of the enzyme, in order to boost the body’s antioxidant defense system, has been ineffective due to the biochemical conditions experienced as the enzyme passes through the gastrointestinal tract. This passage degrades the enzyme, rendering it useless. This publication reviews the science related to GliSODin®, a trade name for SOD extracted from cantaloupe melon and combined with wheat gliadin. Clinical research and scientific evidence is presented to demonstrate that gliadin protects SOD during passage through the stomach, thus allowing absorption of the SOD enzyme once inside the intestine.

Downloads

Download data is not yet available.

References

Halliwell B., Gutteridge J.M.C., Cross C.E., “Free radicals, antioxidants, and human disease: where are we now?” J. Lab Clin Med (1992) Volume 119, Pages 598-620

Ding Q., Dimayuga E., Keller J.N., “Oxidative damage, protein synthesis, and protein degradation in Alzheimer’s disease” Current Alzheimer Research. 2007, Volume 4, Pages 73-79

McCord J.M., Fridovich I., “Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein)” J. Biol. Chem., (1969) Volume 224, Pages 6049-6055

Clemente M.G., De Virgiliis S., Kang J.S., Macatagney R., Musu M.P., Di Pierro M.R., Drago S., Congia M., Fasano A., “Early effects of gliadin on enterocyte intracellular signaling involved in intestinal barrier function” Gut 2003, Volume 52, Pages 218-223

Vouldoukis I., Conti M., Krauss P., Kamaté C., Blazquez S., Tefit M., Mazier D., Calenda A., Dugas B., “Supplementation with gliadin-combined plant superoxide dismutase extract promotes antioxidant defences and protects against oxidative stress” Phytotherapy Research 2004, Volume 18, Pages 957-962

Zainumi C.M., Siregar G.A., Wijaya D.W., Ichwan M. Comparison enteral superoxide dismutase 1 IU and 5 IU from Cucumis melo L.C extract combined with gliadin as an antioxidant and anti-inflammatory in LPS-Induced sepsis model rats. Heliyon 2022 Aug 18;8(8):e10236

Hininger-Favier I., Osman M., Roussel AM.M., Intes L., Montanari B. Positive effects of an oral supplementation by Glisodin, a gliadin-combined SOD-rich melon extract, in an animal model of dietary-induced oxidative stress, Phytothérapie, 2015

Nakamura A. Kitamura N., Yokoyama Y. Uchida S., Kumadaki K.,Tsubota K. and Watanabe M. Melon GliSODin® Prevents Diet-Induced NASH Onset by Reducing Fat Synthesis and Improving Liver Function. Nutrients 2019, 11, 1779

Baba-Ahmed F., Guedri K., Trea F., Ouali K.Protective role of a melon superoxide dismutase combined with gliadin (GliSODin) on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. J Can ResTher. 2021: 17: 6: 1445-1453

Okada F., Shionoya H., Kobayashi M., Kobayashi T., Tazawa H., Onuma K., Iuchi Y., Matsubara N., Ijichi T., Dugas B. and Hosokawa M. Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase. British Journal of Cancer (2006) 94, 854 – 862

M. Cloarec, P. Caillard, J.-C. Provost, J.-M. Dever, Y. Elbeze, N. Zamaria. Glisodin®, a vegetal SOD with gliadin, as preventive agent vs. Atherosclerosis , as confirmed with carotid ultrasound-B imaging. European Annals of Allergy and Clinical Immunology –2007; volume 39 - n° 2

De Lorgeril M., Renaud S., Mamelle N. et al. - Mediterranean alpha-linolenic acid rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-1459

Fontas E., Montaudié H., Passeron T. Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: A 24-week prospective randomized placebo-controlled study. J EurAcad Dermatol Venereol. 2021 Aug;35(8):1725-1729.

Vedamurthy M., Humbert P. A randomized, open label, comparative, five-arm, controlled study evaluating the benefit and tolerability of oral superoxide dismutase combined with gliadin as add-on neutraceutical therapy with standard therapy in Indian patients with melasma. International Journal of Research in Dermatology | October-December 2018/ Vol 4. Issue 4. 471-47

Koike M., Nagao M., Iwase Y., Kaneko K.,Ishijima M., Nojiri H. Clinical Efficacy of Melon GliSODin® for the Treatment of Aging-Related Dysfunction in Motor Organs—A Double Blind, Randomized Placebo-Controlled Study. J Clin Med. 2022 May; 11(10): 2747.

Muth C.M., Glenz Y., Klaus M., Radermacher P., Speit G. and Leverve X. Influence of an Orally Effective SOD on Hyperbaric Oxygen-related Cell Damage. Free Radical Research, Volume 38 Number 9 (September 2004), pp. 927–932.

Endaryanto A., Hikmah Z., Harsono A. Use of Superoxide Dismutase in Accelerating Symptom Relief in Asthmatic and House Dust Mite Allergic Children Receiving House Dust Mite Immunotherapy. International Journal

Published

2022-12-17

How to Cite

Eric, P., I. . Laurent, and V. François. “Immunomodulatory and Anti-Inflammatory Properties of an Orally Bioavailable Sod-Gliadin Complex”. UPI Journal of Pharmaceutical, Medical and Health Sciences, vol. 5, no. 4, Dec. 2022, pp. 68-74, doi:10.37022/jpmhs.v5i4.84.

Issue

Section

Review Article(s)

Citations